PDL Biopharma
PDLI
#8062
Rank
โ‚น25.65 B
Marketcap
โ‚น224.62
Share price
-8.52%
Change (1 day)
N/A
Change (1 year)

Earnings for PDL Biopharma (PDLI)

Earnings in 2020 (TTM): -โ‚น9.63 Billion

According to PDL Biopharma 's latest financial reports the company's current earnings are โ‚น80.61 Million. In 2019 the company made an earning of -โ‚น5.67 Billion a decrease over its 2018 earnings that were of -โ‚น3.98 Billion.

Earnings history for PDL Biopharma from 2001 to 2020

Annual earnings

Year Earnings Change
2020 (TTM)-โ‚น9.63 Billion69.71%
2019-โ‚น5.67 Billion42.43%
2018-โ‚น3.98 Billion-121.38%
2017โ‚น18.61 B60.41%
2016โ‚น11.60 B-77.09%
2015โ‚น50.67 B3.09%
2014โ‚น49.15 B26.65%
2013โ‚น38.80 B19.82%
2012โ‚น32.38 B3.68%
2011โ‚น31.23 B77.17%
2010โ‚น17.63 B-35.29%
2009โ‚น27.24 B23.45%
2008โ‚น22.07 B-1751.42%
2007-โ‚น1.34 Billion-88.56%
2006-โ‚น11.69 Billion93.73%
2005-โ‚น6.03 Billion13.63%
2004-โ‚น5.31 Billion32.12%
2003-โ‚น4.02 Billion87.44%
2002-โ‚น2.15 Billion-302.45%
2001โ‚น1.05 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
โ‚น2.046 T-17,205.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น749.68 B-6,366.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-โ‚น9.92 Billion-17.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
-โ‚น2.51 Billion-79.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Nektar Therapeutics
NKTR
-โ‚น10.35 Billion-13.51%๐Ÿ‡บ๐Ÿ‡ธ USA